28 records found.
Mar 04, 2019
Lilly to Introduce Lower-Priced Insulin
Feb 21, 2019
Smart Insulin Pen Market to Reach a Market Size of $117.3 Million by 2024 - KBV Research
Feb 20, 2019
Abbott and Novo Nordisk Enter Partnership to Provide Integrated Digital Solution to People with Diabetes Using Insulin
Feb 19, 2019
Glooko Announces on-the-go Insulin Pen Data Uploads via Diasend®, Increased CGM Compatibility - and the all-new Annual Diabetes Report
Jan 24, 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
Nov 21, 2018
Global Insulin Delivery Devices Market 2017-2018 & 2025: Opportunities in Increasing Medical Tourism In Emerging Nations & Growing Product Innovations
Nov 15, 2018
Global Syringes Industry
Sep 21, 2018
Diabetes Insulin Delivery Pens (Reusable & Prefilled) Market, 2025
Aug 14, 2018
Diabetes Devices Market Size Worth $35.5 Billion by 2024 | CAGR 7.0%: Grand View Research, Inc.
Aug 01, 2018
Lilly Diabetes Solution Center Now Open to Help People with Insulin Affordability
Jul 19, 2018
Companion Medical Announces CE Mark of InPen(TM) System
Jul 12, 2018
New Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin Affordability
Jun 25, 2018
First-ever Study of Lilly's Humulin® R U-500 Administered in an Insulin Pump Shows Improved A1C in People with Type 2 Diabetes
May 03, 2018
Convenient prefilled insulin pen with flexible half-unit dosing approved and available in Canada
Mar 28, 2018
Global Syringes (Disposable and Reusable) Market, 2024
Mar 27, 2018
FDA approves Toujeo® Max SoloStar®
Feb 27, 2018
Injection Pen Market Worth 41.38 Billion USD by 2022
Dec 05, 2017
Global Insulin Delivery Pen Market Analysis 2012-2017 - Forecasts 2018-2025 Featuring Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed & Biocon
Nov 28, 2017
Insulin Pen Needles Market Value to Reach US$ 3,800 Million by the End of 2026: Transparency Market Research
Nov 21, 2017
United States $6 Billion Insulin Delivery Devices Market Outlook to 2022 - Major Players are Insulet, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi & Owen Mumford

Pages